Vascular Function Clinical Trial
Official title:
The Effects of Macronutrients on Postprandial Vascular Function in Overweight and Slightly Obese Men
Verified date | September 2018 |
Source | Maastricht University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Vascular function decreases following the intake of a mixed meal in some, but not all studies. Differences in the relative amounts of dietary fat, carbohydrates and protein present in the mixed-meal challenges may have contributed to these apparently inconsistent results. Well-designed trials - comparing under rigorously standardized conditions - on the effects of macronutrients on postprandial vascular function are missing. The primary objective of the current study is thus to evaluate in overweight and slightly obese men the effects of the three macronutrients (fat, carbohydrates, and protein) on postprandial vascular function, as assessed by brachial artery flow-mediated vasodilation (FMD). Secondary objectives are to examine postprandial effects on other markers reflecting vascular function, plasma markers for low-grade systemic inflammation and endothelial dysfunction, blood pressure, and serum lipid and plasma glucose metabolism.
Status | Completed |
Enrollment | 20 |
Est. completion date | September 1, 2018 |
Est. primary completion date | September 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Aged between 18-70 years - Men - BMI between 25-35 kg/m2 (overweight and slightly obese) - Fasting plasma glucose < 7.0 mmol/L - Fasting serum total cholesterol < 8.0 mmol/L - Fasting serum triacylglycerol < 2.2 mmol/L - Systolic blood pressure < 160 mmHg and diastolic blood pressure < 100 mmHg - No current smoker - No diabetic patients - No familial hypercholesterolemia - No abuse of drugs - No more than 3 alcoholic consumptions per day - Stable body weight (weight gain or loss < 3 kg in the past three months) - No use of dietary supplements known to interfere with the main study outcomes as judged by the principal investigator - No use of medication to treat blood pressure, lipid or glucose metabolism - No use of an investigational product within another biomedical intervention trial within the previous 1-month - No severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis - No active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident - Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study - No difficult venipuncture as evidenced during the screening visit Exclusion Criteria: - Women - Fasting plasma glucose = 7.0 mmol/L - Fasting serum total cholesterol = 8.0 mmol/L - Fasting serum triacylglycerol = 2.2 mmol/L - Systolic blood pressure = 160 mmHg and/or diastolic blood pressure = 100 mmHg - Current smoker, or smoking cessation < 12 months - Diabetic patients - Familial hypercholesterolemia - Abuse of drugs - More than 3 alcoholic consumptions per day - Unstable body weight (weight gain or loss > 3 kg in the past three months) - Use of dietary supplements known to interfere with the main study outcomes as judged by the principal investigator - Use medication to treat blood pressure, lipid or glucose metabolism - Use of an investigational product within another biomedical intervention trial within the previous 1-month - Severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis - Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident - Not willing to give up being a blood donor from 8 weeks before the start of the study, during the study or for 4 weeks after completion of the study - Not or difficult to venipuncture as evidenced during the screening visit |
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht University Medical Center | Maastricht |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Vascular endothelial function | Flow-mediated vasodilation (FMD) of the brachial artery | Change from baseline at 2 hours after milkshake consumption | |
Secondary | Vascular function markers | Carotid-femoral pulse wave velocity (PWV), pulse wave analysis (PWA), retinal microvascular caliber | Change from baseline at 2 hours after milkshake consumption | |
Secondary | Cardiometabolic risk markers | Plasma markers for low-grade systemic inflammation and endothelial dysfunction | Change from baseline at 2 hours after milkshake consumption | |
Secondary | Cardiometabolic risk markers | Office blood pressure | During 4 hours following milkshake consumption | |
Secondary | Postprandial metabolism | Serum lipid and plasma glucose metabolism | During 4 hours following milkshake consumption |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03866343 -
Restriction of Dietary AGEs to Prevent Diabetes in Overweight Individuals
|
N/A | |
Completed |
NCT01945970 -
Effect of Black Tea on Vascular Function
|
N/A | |
Completed |
NCT02065271 -
Herbal Preparation and Glucose Homeostasis
|
N/A | |
Completed |
NCT01495325 -
Effect of Woodsmoke on Vascular Function
|
N/A | |
Terminated |
NCT04239482 -
Nutritional Supplementation and Insulin Sensitivity
|
N/A | |
Completed |
NCT02273323 -
Flow Mediated Dilation in Response to Black Tea
|
N/A | |
Completed |
NCT04550026 -
Cardiovascular Effects of Heated Tobacco Products (HTP)
|
N/A | |
Completed |
NCT03849300 -
Impacts of Aquatic vs Land Walking on Vascular Health and Exercise Tolerance in Patients With Peripheral Artery Disease
|
N/A | |
Terminated |
NCT04770155 -
Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1
|
Early Phase 1 | |
Active, not recruiting |
NCT01312168 -
Endothelial Dysfunction, Monocyte Activation, and Vasculopathy in Patients With Obstructive Sleep Apnea (OSA) and Effect of 6-month CPAP Treatment
|
N/A | |
Not yet recruiting |
NCT06440512 -
The Effect of Chocolate on Vascular Function of Endurance Runners
|
N/A | |
Not yet recruiting |
NCT06229873 -
Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure
|
N/A | |
Recruiting |
NCT05468255 -
The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults
|
N/A | |
Completed |
NCT01805063 -
Effect of Fire Suppression and Emergency Duties on Vascular Function
|
||
Completed |
NCT04700241 -
Nitrate and Brain Insulin-Sensitivity
|
N/A | |
Completed |
NCT02328339 -
Tea and Forearm Blood Flow
|
N/A | |
Completed |
NCT01575041 -
The Effects of Sodium and Potassium on Blood Pressure, Vascular Function and Renal Function
|
N/A | |
Completed |
NCT03324256 -
Energy Drinks and Vascular Function
|
N/A | |
Completed |
NCT04175457 -
The Acute Effects of E-cigarette Inhalation on Vascular Function, Microcirculation and Thrombosis
|
N/A | |
Completed |
NCT01053026 -
Evaluation of Effects of Exercise Training and ARB in DM Patients
|
N/A |